Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVOTF) EBITDA (2019 - 2025)

Historic EBITDA for Evotec SE (EVOTF) over the last 9 years, with Q3 2025 value amounting to -$52025.3.

  • Evotec SE's EBITDA fell 7881.1% to -$52025.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$152.3 million, marking a year-over-year decrease of 19216602.39%. This contributed to the annual value of -$152.3 million for FY2024, which is 28200857.59% down from last year.
  • As of Q3 2025, Evotec SE's EBITDA stood at -$52025.3, which was down 7881.1% from -$152.1 million recorded in Q4 2024.
  • Evotec SE's 5-year EBITDA high stood at $80176.4 for Q4 2021, and its period low was -$152.1 million during Q4 2024.
  • In the last 5 years, Evotec SE's EBITDA had a median value of $10878.3 in 2023 and averaged -$9.5 million.
  • As far as peak fluctuations go, Evotec SE's EBITDA skyrocketed by 1872.62% in 2023, and later plummeted by 28171324.86% in 2024.
  • Quarter analysis of 5 years shows Evotec SE's EBITDA stood at $80176.4 in 2021, then plummeted by 43.25% to $45503.0 in 2022, then rose by 18.73% to $54024.0 in 2023, then plummeted by 281713.25% to -$152.1 million in 2024, then skyrocketed by 99.97% to -$52025.3 in 2025.
  • Its last three reported values are -$52025.3 in Q3 2025, -$152.1 million for Q4 2024, and -$29095.1 during Q3 2024.